Product Code: RP-ID-10236275 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10236275
Market Overview:
Global Neurorehabilitation Devices Market Size study, by Products (Neuro-Robotic Systems, Brain-Computer Interface, Non-Invasive Stimulators, Wearable Devices) By Applications( Cerebral Palsy, Parkinson’s Disease, Spinal Cord Injury, Traumatic Brain Injury, Stroke) By End-Users (Cognitive Care Centers, Hospitals/Clinics, Research Institutes, Other End-Users) and Regional Forecasts 2019-2026
Global Neurorehabilitation Devices Market is valued approximately at USD 1378.9 million in 2018 and is anticipated to grow with a healthy growth rate of more than 15.50% over the forecast period 2019-2026. Neurorehabilitation devices are used in the treatment of the neurological disorders such as Alzheimer’s disease, migraine, Parkinson’s, epilepsy, brain stroke, multiple sclerosis, neurodegeneration etc. Neurorehabilitation helps in improving the functions, reducing the symptoms and also in improving the well-being of the patients suffering from neurological diseases. There has been rising prevalence of neurological diseases which has led to the increased adoption of neurorehabilitation devices for diagnosis and treatment of neurological diseases. According to World Health Organization (WHO), approximately 6 million deaths occur due to stroke each year. Furthermore, as per WHO, epilepsy is a common neurological disease and approximately 50 million people (as in 2016) globally suffer from epilepsy and 2.4 million people are diagnosed with epilepsy each year. According to world economic forum, the numbers of Parkinson’s disease patients are expected to reach 8.7 million worldwide by 2030 as compared to 4.1 million in 2005. Increasing prevalence of neurological diseases, geriatric population and Emergence of wearables and robotics are key driving factors for market growth. Moreover, rising patient base in emerging economies is expected to create significant growth opportunity in the market over the forecast period. However, High cost of treatment impedes the growth of the market over the forecast period of 2019-2026.
The regional analysis of global Neurorehabilitation Devices market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the growing prevalence of neurological diseases coupled with the well-established healthcare infrastructure. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as rising incidences of neurological disorders coupled with increasing geriatric population and improving healthcare infrastructure would create lucrative growth prospects for the Neurorehabilitation Devices market across Asia-Pacific region.
Major market player included in this report are:
Bioxtreme Robotics Rehabilitation
Ectron Limited
Ekso Bionics Holdings, Inc.
Helius Medical Technologies
Hocoma Ag
Kinestica
Kinova Robotics
Medtronic, Inc.
Neurostyle Pte, Ltd.
St. Jude Medical, Inc. (Acquired by Abbott Laboratories)
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Products:
Neuro-Robotic Systems
Brain-Computer Interface
Non-Invasive Stimulators
Wearable Devices
By Applications:
Cerebral Palsy
Parkinson’s Disease
Spinal Cord Injury
Traumatic Brain Injury
Stroke
By End-Users:
Cognitive Care Centers
Hospitals/Clinics
Research Institutes
Other End-Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026
Target Audience of the Global Neurorehabilitation Devices Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Ectron Limited
Ekso Bionics Holdings, Inc.
Helius Medical Technologies
Hocoma Ag
Kinestica
Kinova Robotics
Medtronic, Inc.
Neurostyle Pte, Ltd.
St. Jude Medical, Inc. (Acquired by Abbott Laboratories)
Related Reports
Proof of Quality & Reliability
